We focus on delivering carefully selected cognition models which are disease-relevant thereby offering the option to evaluate NCEs against pharmacologically induced cognition impairments, (e.g scopolamine) or natural impairments, (age, test parametric manipulation) across multiple disease areas.

Examples of the models we offer include the following:

  • Novel object recognition
    • temporal deficit
    • pharmacological deficit, (scopolamine, sub-chronic PCP)
  • Delayed-non-match to position
  • Reversal learning
  • Attentional set shifting

cognitiveThis list is not exhaustive, we are always developing new areas of discovery within our preclinical field of expertise. If there is something particular that is not listed here please do contact us.